Panbela Therapeutics CEO Jennifer Simpson's 2021 pay jumps 372% to $1.2M
Panbela Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 29, 2022
Panbela Therapeutics reported fiscal year 2021 executive compensation information on April 29, 2022.
In 2021, three executives at Panbela Therapeutics received on average a compensation package of $770K, a 16% decrease compared to previous year.
Average pay of disclosed executives at Panbela Therapeutics
Jennifer K. Simpson, Chief Executive Officer, received $1.2M in total, which decreased by 31% compared to 2020. 45% of Simpson's compensation, or $538K, was in option awards. Simpson also received $182K in non-equity incentive plan and $477K in salary.
Susan Horvath, Chief Financial Officer, received a compensation package of $557K, which increased by 35% compared to previous year. 54% of the compensation package, or $302K, was in salary.
Michael T. Cullen, Chairman, earned $555K in 2021, a 9% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 29, 2022.